Current Neuropharmacology
Volume 19, 12 Issues, 2021
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
Contents
Current Neuropharmacology, Volume 14 - Number 4
Editorial
Editorial (Thematic Selection: Strategies of Current Drugs and Alternative Treatments for Neurodegenerative Diseases)
, 14(4): 301Xiao-Ping Wang and Hong-Zhuan Chen
DOI: 10.2174/1570159X1404160408124344
Freezing of Gait in Parkinsonism and its Potential Drug Treatment
, 14(4): 302 - 306Li-Li Zhang, S. Duff Canning and Xiao-Ping Wang
DOI: 10.2174/1570159X14666151201190040
Freezing of Gait in Parkinsonism and its Potential Drug Treatment
Drug Therapy for Behavioral and Psychological Symptoms of Dementia
, 14(4): 307 - 313Feng Wang, Ting-Yi Feng, Shilin Yang, Maurice Preter, Jiang-Ning Zhou and Xiao-Ping Wang
DOI: 10.2174/1570159X14666151208114232
Drug Therapy for Behavioral and Psychological Symptoms of Dementia
Current Therapy of Drugs in Amyotrophic Lateral Sclerosis
, 14(4): 314 - 321Haiyan Lu, Wei Dong Le, Ya-Ying Xie and Xiao-Ping Wang
DOI: 10.2174/1570159X14666160120152423
Current Therapy of Drugs in Amyotrophic Lateral Sclerosis
Current Drug Managements of Wilson’s Disease: From West to East
, 14(4): 322 - 325Wen-Jie Li, Chen Chen, Zhi-Fei You, Ren-Min Yang and Xiao-Ping Wang
DOI: 10.2174/1570159X14666151130222427
Current Drug Managements of Wilson’s Disease: From West to East
Current Treatment Options for Alzheimer’s Disease and Parkinson’s Disease Dementia
, 14(4): 326 - 338Jennifer Y.Y. Szeto and Simon J.G. Lewis
DOI: 10.2174/1570159X14666151208112754
Current Treatment Options for Alzheimer’s Disease and Parkinson’s Disease Dementia
Current Pharmaceutical Treatments and Alternative Therapies of Parkinson’s Disease
, 14(4): 339 - 355Jie Dong, Yanhua Cui, Song Li and Weidong Le
DOI: 10.2174/1570159X14666151120123025
Current Pharmaceutical Treatments and Alternative Therapies of Parkinson’s Disease
Revisiting the Medical Management of Parkinson’s Disease: Levodopa versus Dopamine Agonist
, 14(4): 356 - 363Jinglin Zhang and Louis Chew-Seng Tan
DOI: 10.2174/1570159X14666151208114634
Revisiting the Medical Management of Parkinson’s Disease: Levodopa versus Dopamine Agonist
AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer’s Disease
, 14(4): 364 - 375Yu Wang, Hao Wang and Hong-zhuan Chen
DOI: 10.2174/1570159X14666160119094820
AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer’s Disease
Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease
, 14(4): 376 - 391Mine Silindir Gunay, A. Yekta Ozer and Sylvie Chalon
DOI: 10.2174/1570159X14666151230124904
Molecular, Cellular and Clinical Aspects of Intracerebral Hemorrhage: Are the Enemies Within?
, 14(4): 392 - 402Cássia Righy, Marcelo T. Bozza, Marcus F. Oliveira and Fernando A. Bozza
DOI: 10.2174/1570159X14666151230110058
Molecular, Cellular and Clinical Aspects of Intracerebral Hemorrhage: Are the Enemies Within?
Editor-in-Chief
Ferdinando Nicoletti
Department of Pharmaceutical Sciences
University Rome"da Sapienza"
Rome
(Italy)
Department of Pharmaceutical Sciences
University Rome"da Sapienza"
Rome
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
New eBook
 |
Neurobiology of Mood DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Webmaster Contact: info@benthamscience.net